Literature DB >> 11234786

Determinants of persistent and recurrent Chlamydia trachomatis infection in young women: results of a multicenter cohort study.

W L Whittington1, C Kent, P Kissinger, M K Oh, J D Fortenberry, S E Hillis, B Litchfield, G A Bolan, M E St Louis, T A Farley, H H Handsfield.   

Abstract

BACKGROUND: Sequelae of genital Chlamydia trachomatis infection in women are more strongly linked to repeat infections than to initial ones, and persistent or subsequent infections foster continued transmission.
OBJECTIVE: To identify factors associated with persistent and recurrent chlamydial infection in young women that might influence prevention strategies.
METHODS: Teenage and young adult women with uncomplicated C trachomatis infection attending reproductive health, sexually transmitted disease, and adolescent medicine clinics in five US cities were recruited to a cohort study. Persistent or recurrent chlamydial infection was detected by ligase chain reaction (LCR) testing of urine 1 month and 4 months after treatment.
RESULTS: Among 1,194 women treated for chlamydial infection, 792 (66.4%) returned for the first follow-up visit, 50 (6.3 %) of whom had positive LCR results. At that visit, women who resumed sex since treatment were more likely to have chlamydial infection (relative risk [RR], 2.0; 95% CI, 1.03-3.9), as were those who did not complete treatment (RR, 3.4; 95% CI, 1.6-7.3). Among women who tested negative for C trachomatis at the first follow-up visit, 36 (7.1%) of 505 had positive results by LCR at the second follow-up visit. Reinfection at this visit was not clearly associated with having a new sex partner or other sexual behavior risks; new infection was likely due to resumption of sex with untreated partners. Overall, 13.4% of women had persistent infection or became reinfected after a median of 4.3 months, a rate of 33 infections per 1,000 person months.
CONCLUSIONS: Persistent or recurrent infection is very common in young women with chlamydial infection. Improved strategies are needed to assure treatment of women's male sex partners. Rescreening, or retesting of women for chlamydial infection a few months after treatment, also is recommended as a routine chlamydia prevention strategy.

Entities:  

Mesh:

Year:  2001        PMID: 11234786     DOI: 10.1097/00007435-200102000-00011

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  50 in total

1.  Provider willingness to screen all sexually active adolescents for chlamydia.

Authors:  B O Boekeloo; M H Snyder; M Bobbin; G R Burstein; D Conley; T C Quinn; J M Zenilman
Journal:  Sex Transm Infect       Date:  2002-10       Impact factor: 3.519

2.  Assessing non-response to a mailed health survey including self-collection of biological material.

Authors:  Anneli Uusküla; Mart Kals; Louise-Anne McNutt
Journal:  Eur J Public Health       Date:  2010-05-10       Impact factor: 3.367

3.  Population-based genetic and evolutionary analysis of Chlamydia trachomatis urogenital strain variation in the United States.

Authors:  Kim Millman; Carolyn M Black; Robert E Johnson; Walter E Stamm; Robert B Jones; Edward W Hook; David H Martin; Gail Bolan; Simon Tavaré; Deborah Dean
Journal:  J Bacteriol       Date:  2004-04       Impact factor: 3.490

4.  Incidence of sexually transmitted infections among hazardously drinking women after incarceration.

Authors:  Michael D Stein; Celeste M Caviness; Bradley J Anderson
Journal:  Womens Health Issues       Date:  2011-08-10

5.  Canadian guidelines on sexually transmitted infections, 2006.

Authors:  Noni MacDonald; Tom Wong
Journal:  CMAJ       Date:  2007-01-16       Impact factor: 8.262

6.  Rifalazil pretreatment of mammalian cell cultures prevents subsequent Chlamydia infection.

Authors:  Robert J Suchland; Kara Brown; David M Rothstein; Walter E Stamm
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

7.  Associations of a sexually transmitted disease diagnosis during a relationship with condom use and psychosocial outcomes: (short) windows of opportunity.

Authors:  Allecia E Reid; Urania Magriples; Linda M Niccolai; Derrick M Gordon; Anna A Divney; Trace S Kershaw
Journal:  Am J Community Psychol       Date:  2013-06

8.  Serovar-specific immune responses to peptides of variable regions of Chlamydia trachomatis major outer membrane protein in serovar D-infected women.

Authors:  Pragya Srivastava; Rishein Gupta; Hem Chandra Jha; Rajneesh Jha; Apurb Rashmi Bhengraj; Sudha Salhan; Aruna Mittal
Journal:  Clin Exp Med       Date:  2008-09-25       Impact factor: 3.984

Review 9.  It takes 2: partner attributes associated with sexually transmitted infections among adolescents.

Authors:  Andrea Swartzendruber; Jonathan M Zenilman; Linda M Niccolai; Trace S Kershaw; Jennifer L Brown; Ralph J Diclemente; Jessica M Sales
Journal:  Sex Transm Dis       Date:  2013-05       Impact factor: 2.830

10.  Repeat chlamydia screening by mail, San Francisco.

Authors:  P J Bloomfield; K C Steiner; C K Kent; J D Klausner
Journal:  Sex Transm Infect       Date:  2003-02       Impact factor: 3.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.